Scott Treiber
EXECUTIVE VICE PRESIDENT, BIOPHARMACEUTICAL DEVELOPMENT AND
Chiltern International
Singapore
Biography
He is a founding member of the Clinical Research Exchange and is active in the Chicagoland Chapter of the Association of Clinical Research Professionals. He earned his bachelor’s degree from the University of Iowa, a PhD in biology from the University of California, Santa Cruz, and an MBA from Ellis College at the New York Institute of Technology. He is based near Chicago, Illinois
Research Interest
A seasoned veteran with expertise in clinical operations, clinical development, medical affairs, data management, statistics and pharmacovigilance, Dr. Scott Treiber oversees all aspects of Chiltern’s biopharmaceutical development. His oversight encompasses early phase, first-in-human and proof-of-concept studies and Phase II-IV studies across a wide range of therapeutic areas, and he also provides executive oversight for our Latin America region.
